Esomeprazole
Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
---|---|---|---|---|---|---|
NexIUM | DELAYED RELEASE CAPSULE, ORAL | 20 mg, 40 mg | ||||
Esomeprazole Strontium | DELAYED RELEASE CAPSULE, ORAL | 24.65 mg, 49.3 mg | ||||
NexIUM | GRANULE FOR RECONSTITUTION, ORAL | 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg | ||||
NexIUM I.V. | POWDER FOR INJECTION, INTRAVENOUS | 20 mg | ||||
NexIUM I.V. | POWDER FOR INJECTION, INTRAVENOUS | 40 mg | ||||
NexIUM | POWDER FOR RECONSTITUTION, DELAYED RELEASE, ORAL | 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg |
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
esomeprazole (Esomeprazole Strontium)
pantoprazole (Protonix)
esomeprazole (NexIUM)
pantoprazole (Protonix)
esomeprazole (NexIUM I.V.)
pantoprazole (Protonix IV)
NexIUM I.V. and oral capsules are restricted to no substitution orders.
Pediatrics: Esomeprazole granules are the preferred dosage form in patients unable to take tablets or capsules. Lansoprazole SoluTab or lansoprazole solution may be used as alternatives if needed based on the clinical scenario and tolerability of the patient.
NexIUM DR capsules and DR oral suspension medication guide
Reviewed: October 28, 2008, and May 27, 2014 (Esomeprazole Strontium), and 26 May 2015 (NexIUM DR granules), and 27 Feb 2018 (Pediatric Suspension Dosing)
Updated: October 2022 (Pediatric PPI Update), October 2023 (Pediatric PPI Update)